Biora Therapeutics, Inc.
BIORQ
$0.1174
-$0.0086-6.83%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -384.64% | 254.33% | -- | -- | -312.50% |
| Total Depreciation and Amortization | 0.91% | 4.76% | -- | -- | -24.70% |
| Total Amortization of Deferred Charges | 175.59% | -82.47% | -- | -- | -3.66% |
| Total Other Non-Cash Items | 107.02% | -68.78% | -- | -- | 2,620.18% |
| Change in Net Operating Assets | 109.92% | 51.11% | -- | -- | -20.20% |
| Cash from Operations | 20.29% | 12.36% | -- | -- | 5.06% |
| Capital Expenditure | 89.44% | -1,100.00% | -- | -- | 95.00% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Investing | 89.44% | -105.99% | -- | -- | 94.74% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -89.01% | 17.93% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -174.65% | 555.17% | -- | -- | -139.70% |
| Cash from Financing | 17.44% | 10.53% | -- | -- | -137.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.26% | -25.14% | -- | -- | -246.12% |
